Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Deal Origination Executive Search For Sales Teams Corporate Development For Founders For Agencies For Investors Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Start Free
Sinopharm logo — company profile

Sinopharm

Founded 2015 329 employees Series B Total: $420.00M Pharmaceutical, Retail

General Information

Company Name Sinopharm
Founded Year 2015
Employees 329
Industries Pharmaceutical, Retail
Funding Stage Series B
Social

Get notified when Sinopharm moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Sinopharm

Sinopharm is a leading pharmaceutical and healthcare group in China, operating under the State-Owned Assets Supervision and Administration Commission of the State Council (SASAC). Established in 2015, the company is primarily engaged in pharmaceutical distribution, scientific research, and the manufacturing of medical and biotech products. With 16 wholly-owned subsidiaries and holding companies, as well as multiple listed entities, including Sinopharm Group Co., Ltd., China National Medicines Co., Ltd. (CNCM), Beijing Tiantan Biological Products Co., Ltd. (TiantanBio), Shyndec Pharmaceutical Co., Ltd. (Shyndec), and Shenzhen Accord Pharmaceutical Co., Ltd. (Accord), Sinopharm has established itself as a key player in the industry. In 2009, the company recorded a revenue of 65 billion Yuan, ranking 50th among central enterprises in terms of revenue and 38th in total profit. The anticipated revenue for 2010 is 80 billion Yuan. Notably, Sinopharm received a CNY300.00M Series B investment on 26 April 2019, with participation from Galaxy Yuanhui Investment, Ample Harvest Finance, ShenZhen GTJA Investment Group, V-Capital, and Frontline BioVentures. With its significant market presence and strategic investments, Sinopharm continues to solidify its position within the pharmaceutical and retail sectors.

Taxonomy: pharmaceutical distribution, scientific research, medical products, biotech products, pharmaceutical manufacture, healthcare group, pharmaceutical industry, state-owned enterprise, central enterprise, chemical reagents, import & export, R&D, bio-pharm, traditional medicine

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Series B •••••• 5 •••• •••• 26 Apr 2019
Series A •••••• 2
Investor
•••• •••• 		05 Jul 2017
Angel Round •••••• 1 •••• •••• 22 Sep 2016

Sinopharm Alternatives & Competitors

Sinopharm vs
LIVZON PHARMACEUTICAL GROUP INC.
LIVZON PHARMACEUTICAL GROUP INC. China

Mission is to dedicate to the cause of human health Vision is to become the world’s leading pharmace...

652 employees
Biotechnology, Health Care
Sinopharm vs
Cangzhou Mingzhu Plastic Co., Ltd.
Cangzhou Mingzhu Plastic Co., Ltd. China

We make all our efforts for your better life !

103 employees
Manufacturing
Sinopharm vs
China Meheco Corporation
China Meheco Corporation China

Committed to advancing human health and pursuing excellence, striving to lead in the pharmaceutical...

67 employees
Health Care, Pharmaceutical

FAQ About Sinopharm

China National Pharmaceutical Group Corporation, SINOPHARM, is the largest pharmaceutical and healthcare group under State-Owned Assets Supervision and Administration Commission of the State Council (SASAC) in China, with core business of pharmaceutical distribution, scientific research and manufact...
Sinopharm was founded in 2015.
Sinopharm operates in the following industries: Pharmaceutical, Retail.
Sinopharm has approximately 329 employees.
Sinopharm has completed 3 funding rounds, raising a total of $420.00M. The latest funding stage is Series B.
Top alternatives and competitors to Sinopharm include LIVZON PHARMACEUTICAL GROUP INC., Cangzhou Mingzhu Plastic Co., Ltd., China Meheco Corporation, Everbright Securities, Dangdai International Group Co., Limited. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Sinopharm and LIVZON PHARMACEUTICAL GROUP INC. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Sinopharm and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Start Tracking — Free

One analytics cookie (Google Analytics). Cookie Policy